Hudson Executive Capital LP Atri Cure, Inc. Transaction History

Hudson Executive Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $2.11 Million - $2.85 Million	-87,678 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $2.38 Million - $3.25 Million	-100,000 Reduced 53.28%	87,678 $2.19 Million
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $6.99 Million - $8 Million	-260,300 Reduced 58.11%	187,678 $5.6 Million
Q1 2019 May 15, 2019	SELL	$26.38 - $33.34 $23.3 Million - $29.4 Million	-881,511 Reduced 66.3%	447,978 $12 Million
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $27.8 Million - $36.4 Million	-1,044,630 Reduced 44.0%	1,329,489 $40.7 Million
Q1 2018 May 15, 2018	BUY	$15.05 - $21.03 $5.55 Million - $7.75 Million	368,509 Added 18.37%	2,374,119 $48.7 Million
Q4 2017 Feb 14, 2018	BUY	$17.69 - $23.44 $2.66 Million - $3.53 Million	150,610 Added 8.12%	2,005,610 $36.6 Million
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $37.1 Million - $44.9 Million	1,855,000	1,855,000 $41.5 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Hudson Executive Capital LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Executive Capital LP with notifications on news.